StonvexLoading…
StonvexStonvexStonvexCore line items from INIS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $13.07M | $13.90M | $12.27M | $11.18M |
Operating Income | $-956.19K | $6.90K | $-776.30K | $-1.20M |
Net Income | $-908.00K | $8.57K | $-869.02K | $303.24K |
EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 |
Total Assets | $17.84M | $17.16M | $16.91M | $16.24M |
Total Liabilities | $14.14M | $12.81M | $12.87M | $11.90M |
Cash & Equivalents | $1.70M | $1.95M | $2.69M | $2.38M |
Free Cash Flow OCF − CapEx | $86.01K | $-82.43K | $433.53K | $-1.62M |
Shares Outstanding | 528.21M | 523.55M | 519.79M | 514.89M |